regulatory
confidence high
sentiment negative
materiality 0.50
Verastem, Inc. (VSTM): Nasdaq/NYSE listing notice — Verastem receives Nasdaq deficiency notice; bid price below $1.00 for 30 days
Verastem, Inc.
- Received deficiency letter on Nov 4, 2022 for failing minimum bid price of $1.00 per share for 30 consecutive business days.
- Must regain compliance by May 3, 2023; eligible for additional 180-day period if met except bid price rule.
- Company may consider reverse stock split to cure; no immediate effect on listing or trading under VSTM.
- No assurance the company will regain compliance; delisting risk remains if not cured by deadline.